Epilepsy-related voltage-gated sodium channelopathies: a review
LFS Menezes, EF Sabiá Júnior, DV Tibery… - Frontiers in …, 2020 - frontiersin.org
Epilepsy is a disease characterized by abnormal brain activity and a predisposition to
generate epileptic seizures, leading to neurobiological, cognitive, psychological, social, and …
generate epileptic seizures, leading to neurobiological, cognitive, psychological, social, and …
Epilepsy and developmental disorders: Next generation sequencing in the clinic
JD Symonds, A McTague - European Journal of Paediatric Neurology, 2020 - Elsevier
Abstract Background The advent of Next Generation Sequencing (NGS) has led to a
redefining of the genetic landscape of the epilepsies. Hundreds of single gene epilepsies …
redefining of the genetic landscape of the epilepsies. Hundreds of single gene epilepsies …
Diagnostic yield of genetic tests in epilepsy: a meta-analysis and cost-effectiveness study
I Sanchez Fernandez, T Loddenkemper… - Neurology, 2019 - AAN Enterprises
Objective To compare the cost-effectiveness of genetic testing strategies in patients with
epilepsy of unknown etiology. Methods This meta-analysis and cost-effectiveness study …
epilepsy of unknown etiology. Methods This meta-analysis and cost-effectiveness study …
STXBP1 encephalopathies: clinical spectrum, disease mechanisms, and therapeutic strategies
D Abramov, NGL Guiberson… - Journal of …, 2021 - Wiley Online Library
Abstract Mutations in Munc18‐1/STXBP1 (syntaxin‐binding protein 1) are linked to various
severe early epileptic encephalopathies and neurodevelopmental disorders. Heterozygous …
severe early epileptic encephalopathies and neurodevelopmental disorders. Heterozygous …
[HTML][HTML] Distinct roles of GRIN2A and GRIN2B variants in neurological conditions
SJ Myers, H Yuan, JQ Kang, FCK Tan… - …, 2019 - ncbi.nlm.nih.gov
Rapid advances in sequencing technology have led to an explosive increase in the number
of genetic variants identified in patients with neurological disease and have also enabled …
of genetic variants identified in patients with neurological disease and have also enabled …
Clinical application of targeted next-generation sequencing panels and whole exome sequencing in childhood epilepsy
G Costain, D Cordeiro, D Matviychuk… - Neuroscience, 2019 - Elsevier
Genetic diagnosis of childhood epilepsy is crucial to provide disease-specific treatments.
This report describes the genetic landscape of childhood epilepsy revealed by targeted next …
This report describes the genetic landscape of childhood epilepsy revealed by targeted next …
Propofol rescues voltage-dependent gating of HCN1 channel epilepsy mutants
ED Kim, X Wu, S Lee, GR Tibbs, KP Cunningham… - Nature, 2024 - nature.com
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are essential for
pacemaking activity and neural signalling,. Drugs inhibiting HCN1 are promising candidates …
pacemaking activity and neural signalling,. Drugs inhibiting HCN1 are promising candidates …
Gain of function SCN1A disease‐causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication
S Matricardi, S Cestèle, M Trivisano, B Kassabian… - …, 2023 - Wiley Online Library
Objective This study was undertaken to refine the spectrum of SCN1A epileptic disorders
other than Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+) …
other than Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+) …
Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impact
P Boonsimma, C Ittiwut, W Kamolvisit, R Ittiwut… - European Journal of …, 2023 - nature.com
Pharmacoresistant epilepsy presenting during infancy poses both diagnostic and
therapeutic challenges. We aim to identify diagnostic yield and treatment implications of …
therapeutic challenges. We aim to identify diagnostic yield and treatment implications of …
SCN1A gain‐of‐function mutation causing an early onset epileptic encephalopathy
Objective Loss‐of‐function variants in SCN1A cause Dravet syndrome, the most common
genetic developmental and epileptic encephalopathy (DEE). However, emerging evidence …
genetic developmental and epileptic encephalopathy (DEE). However, emerging evidence …